Evidence map›Paper›PMID 25753826›Full record

ArticleBiotechnology and bioengineering2015

Bioprocessing analysis of Pyrococcus furiosus strains engineered for CO₂-based 3-hydroxypropionate production.

Aaron B Hawkins, Hong Lian, Benjamin M Zeldes, Andrew J Loder, Gina L Lipscomb, Gerrit J Schut, Matthew W Keller, Michael W W Adams, Robert M Kelly

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Genome sequence ofMicrobiology resource announcements · 2025
    Article
  2. Review
  3. Engineering the hyperthermophilic archaeonApplied and environmental microbiology · 2025
    Article
  4. Article
  5. Article
  6. Biotechnology of extremely thermophilic archaea.FEMS microbiology reviews · 2018
    Review
  7. Article
  8. 'Pyrococcus furiosus, 30 years on'.Microbial biotechnology · 2017
    Article
  9. Physiological, metabolic and biotechnological features of extremely thermophilic microorganisms.Wiley interdisciplinary reviews. Systems biology and medicine · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Aaron B HawkinsDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695-7905.
Hong LianDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695-7905.
Benjamin M ZeldesDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695-7905.
Andrew J LoderDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695-7905.
Gina L LipscombDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, 30602.
Gerrit J SchutDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, 30602.
Matthew W KellerDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, 30602.
Michael W W AdamsDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, 30602.
Robert M KellyDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695-7905. mkelly@ncsu.edu.
North Carolina State University · USUniversity of Georgia · US

Funding

Molecular Biotechnology Training at North Carolina State UniversityT32GM008776 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI KELLY, ROBERT M · 2000 to 2019
$3.9M
NIGMS NIH HHS 2T32GM008776NIGMS NIH HHS T32 GM008776
6 · The paper itself

Abstract

Metabolically engineered strains of the hyperthermophile Pyrococcus furiosus (T(opt) 95-100°C), designed to produce 3-hydroxypropionate (3HP) from maltose and CO2 using enzymes from the Metallosphaera sedula (T(opt) 73°C) carbon fixation cycle, were examined with respect to the impact of heterologous gene expression on metabolic activity, fitness at optimal and sub-optimal temperatures, gas-liquid mass transfer in gas-intensive bioreactors, and potential bottlenecks arising from product formation. Transcriptomic comparisons of wild-type P. furiosus, a genetically-tractable, naturally-competent mutant (COM1), and COM1-based strains engineered for 3HP production revealed numerous differences after being shifted from 95°C to 72°C, where product formation catalyzed by the heterologously-produced M. sedula enzymes occurred. At 72°C, significantly higher levels of metabolic activity and a stress response were evident in 3HP-forming strains compared to the non-producing parent strain (COM1). Gas-liquid mass transfer limitations were apparent, given that 3HP titers and volumetric productivity in stirred bioreactors could be increased over 10-fold by increased agitation and higher CO2 sparging rates, from 18 mg/L to 276 mg/L and from 0.7 mg/L/h to 11 mg/L/h, respectively. 3HP formation triggered transcription of genes for protein stabilization and turnover, RNA degradation, and reactive oxygen species detoxification. The results here support the prospects of using thermally diverse sources of pathways and enzymes in metabolically engineered strains designed for product formation at sub-optimal growth temperatures.

Indexed as

BioreactorsCarbon DioxideGene Expression ProfilingHot TemperatureLactic AcidMaltoseMetabolic EngineeringMetabolic Networks and PathwaysPyrococcus furiosusSulfolobaceaeCarbon Dioxidehydracrylic acidLactic AcidMaltose3-hydroxypropionateCO2 fixationMetallosphaera sedulaPyrococcus furiosus

Identifiers

PMID25753826
PMCPMC4664069
OpenAlexW2138064541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.